Suppression of FUT1 attenuates cell proliferation in the HER2-overexpressing cancer cell line NCI-N87S. Kawai, Chikashi Ishioka|Oncology Reports|2012Cited by 32
Clinical evaluation of pazufloxacin mesilate for chronic respiratory tract infections: Phase III comparative study of pazufloxacin mesilate versus ceftazidimeK Shimada, K Mikasa, Shosaku Abe et al.|Chemotherapy|2000Cited by 0
Clinical evaluation of pazufloxacin mesilate for bacterial pneumonia: Phase III comparative study of pazufloxacin mesilate versus ceftazidimeK. Shimada, Atsushi Yoshitomi, Shosaku Abe et al.|Unknown|2000Cited by 0
Phase II study of intravenously infused pazufloxacin mesilateKousei Shimada, M. Matuda, Eiichi Yamaguchi et al.|Unknown|1999Cited by 0